A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors
Clinical trial NCT06547957 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06547957
- Sponsor
- iTeos Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-07
- Primary completion
- 2025-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.